FDA Inspection 1231900 — BASF Corporation

BASF Corporation — FEI 3001451837

The FDA completed an inspection of BASF Corporation on Sep 11, 2024 in Bishop, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bishop, TX (United States)